科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/05/02 | 3,935 | 3,970 | 3,915 | 3,950 | +15 | +0.4% | 51,800 |
| 2022/04/28 | 3,825 | 3,945 | 3,810 | 3,935 | +125 | +3.3% | 94,900 |
| 2022/04/27 | 3,830 | 3,850 | 3,785 | 3,810 | -40 | -1% | 132,100 |
| 2022/04/26 | 3,860 | 3,885 | 3,845 | 3,850 | ±0 | ±0% | 58,800 |
| 2022/04/25 | 3,835 | 3,865 | 3,820 | 3,850 | -15 | -0.4% | 63,900 |
| 2022/04/22 | 3,845 | 3,880 | 3,840 | 3,865 | -10 | -0.3% | 43,300 |
| 2022/04/21 | 3,850 | 3,890 | 3,850 | 3,875 | +55 | +1.4% | 54,700 |
| 2022/04/20 | 3,820 | 3,835 | 3,790 | 3,820 | +15 | +0.4% | 60,600 |
| 2022/04/19 | 3,810 | 3,815 | 3,775 | 3,805 | +10 | +0.3% | 63,800 |
| 2022/04/18 | 3,800 | 3,805 | 3,760 | 3,795 | -30 | -0.8% | 107,900 |
| 2022/04/15 | 3,870 | 3,885 | 3,815 | 3,825 | -70 | -1.8% | 83,900 |
| 2022/04/14 | 3,880 | 3,905 | 3,875 | 3,895 | ±0 | ±0% | 58,100 |
| 2022/04/13 | 3,895 | 3,915 | 3,870 | 3,895 | ±0 | ±0% | 64,600 |
| 2022/04/12 | 3,945 | 3,950 | 3,895 | 3,895 | -40 | -1% | 68,200 |
| 2022/04/11 | 3,930 | 3,950 | 3,910 | 3,935 | ±0 | ±0% | 79,200 |
| 2022/04/08 | 3,985 | 3,990 | 3,910 | 3,935 | +5 | +0.1% | 93,600 |
| 2022/04/07 | 3,890 | 3,945 | 3,870 | 3,930 | +30 | +0.8% | 124,500 |
| 2022/04/06 | 3,945 | 3,955 | 3,885 | 3,900 | -25 | -0.6% | 148,800 |
| 2022/04/05 | 3,975 | 3,975 | 3,915 | 3,925 | ±0 | ±0% | 67,300 |
| 2022/04/04 | 3,955 | 3,955 | 3,920 | 3,925 | +10 | +0.3% | 52,700 |
| 2022/04/01 | 3,890 | 3,935 | 3,870 | 3,915 | +25 | +0.6% | 106,700 |
| 2022/03/31 | 3,935 | 3,945 | 3,880 | 3,890 | -55 | -1.4% | 130,900 |
| 2022/03/30 | 3,945 | 3,965 | 3,900 | 3,945 | -120 | -3% | 181,400 |
| 2022/03/29 | 4,065 | 4,070 | 4,005 | 4,065 | +10 | +0.2% | 88,700 |
| 2022/03/28 | 4,060 | 4,080 | 4,025 | 4,055 | +35 | +0.9% | 82,600 |
| 2022/03/25 | 3,990 | 4,020 | 3,965 | 4,020 | +60 | +1.5% | 136,800 |
| 2022/03/24 | 3,990 | 4,025 | 3,935 | 3,960 | -80 | -2% | 154,800 |
| 2022/03/23 | 3,960 | 4,045 | 3,940 | 4,040 | +100 | +2.5% | 173,900 |
| 2022/03/22 | 3,955 | 3,990 | 3,880 | 3,940 | +5 | +0.1% | 314,000 |
| 2022/03/18 | 4,180 | 4,180 | 3,935 | 3,935 | -260 | -6.2% | 189,700 |
| 2022/03/17 | 4,270 | 4,270 | 4,180 | 4,195 | -5 | -0.1% | 84,700 |
| 2022/03/16 | 4,135 | 4,235 | 4,130 | 4,200 | +65 | +1.6% | 97,100 |
| 2022/03/15 | 4,075 | 4,150 | 4,070 | 4,135 | +85 | +2.1% | 59,500 |
| 2022/03/14 | 4,135 | 4,145 | 4,035 | 4,050 | -85 | -2.1% | 67,600 |
| 2022/03/11 | 4,160 | 4,185 | 4,135 | 4,135 | -75 | -1.8% | 60,900 |
| 2022/03/10 | 4,190 | 4,220 | 4,160 | 4,210 | +75 | +1.8% | 109,600 |
| 2022/03/09 | 4,100 | 4,145 | 4,100 | 4,135 | +5 | +0.1% | 77,600 |
| 2022/03/08 | 4,125 | 4,155 | 4,110 | 4,130 | +10 | +0.2% | 103,400 |
| 2022/03/07 | 4,110 | 4,125 | 4,085 | 4,120 | +5 | +0.1% | 68,200 |
| 2022/03/04 | 4,130 | 4,180 | 4,115 | 4,115 | -50 | -1.2% | 53,800 |
| 2022/03/03 | 4,105 | 4,195 | 4,105 | 4,165 | +70 | +1.7% | 75,300 |
| 2022/03/02 | 4,130 | 4,155 | 4,090 | 4,095 | -105 | -2.5% | 122,400 |
| 2022/03/01 | 4,240 | 4,250 | 4,195 | 4,200 | -20 | -0.5% | 51,500 |
| 2022/02/28 | 4,135 | 4,230 | 4,135 | 4,220 | +115 | +2.8% | 55,000 |
| 2022/02/25 | 4,165 | 4,190 | 4,085 | 4,105 | -45 | -1.1% | 38,500 |
| 2022/02/24 | 4,100 | 4,160 | 4,080 | 4,150 | +30 | +0.7% | 45,000 |
| 2022/02/22 | 4,120 | 4,140 | 4,105 | 4,120 | -20 | -0.5% | 55,200 |
| 2022/02/21 | 4,160 | 4,165 | 4,120 | 4,140 | -75 | -1.8% | 44,800 |
| 2022/02/18 | 4,215 | 4,240 | 4,180 | 4,215 | +10 | +0.2% | 36,300 |
| 2022/02/17 | 4,300 | 4,305 | 4,200 | 4,205 | -100 | -2.3% | 46,600 |
801～
850
件表示中 / 3757件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 401,900円 | -6.4% | -71.8% | 4.73% | 44.89倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 450,000円 | +3.6% | - | 2.67% | 15.17倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| サンバイオ | 244,500円 | - | - | 0.00% | - | 113.25倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 東和薬品 | 341,500円 | +7.9% | -3.3% | 2.34% | 9.50倍 | 0.98倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
